Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 13

ОБЗОР2026 · pp. 107–116

Genetic architecture and molecular mechanisms of cerebrovascular diseases: ischemic stroke, cerebral small vessel disease and intracranial aneurysms in the context of personalized medicine

Introduction. Cerebrovascular diseases are a heterogeneous group of conditions shaped by the interaction of polygenic susceptibility, rare monogenic variants, vascular remodeling, neuroinflammation, dysregulated hemostasis, and epigenetic reprogramming. Recent…

10.29296/24999490-2026-03-15Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 3–8

Molecular mechanisms of astrocyte involvement in the pathogenesis of Parkinson’s disease

Introduction. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder, the primary pathological feature of which is the death of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of aggregated α-synuclein. Th…

10.29296/24999490-2026-03-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 58–69

Polypragmasy in elderly and senile patients with chronic kidney disease: START/STOP criteria in elderly and senile patients taking DOAC

Introduction. Thanks to the achievements of modern medicine, it was possible to significantly increase the life expectancy of the population. Molecular mechanisms of aging include telomere shortening, DNA damage accumulation, mitochondrial dysfunction, leading…

10.29296/24999490-2025-05-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 54–59

The effect of polymorphism of the NQO1 gene on the content of ubiquinone in blood plasma and the state of functional activity of mitochondria in patients with chronic heart failure

Introduction. Chronic heart failure is a multifactorial disease, an important role in the pathogenesis of which is played by disorders of the functions of mitochondria and energy metabolism in cardiomyocytes, as well as a significant contribution is made by ge…

10.29296/24999490-2025-02-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 43–51

Mitochondrial proteins as biomarkers of occupational disease risk of pilots and astronauts

Introduction. Mitochondrial dysfunction is an important pathogenic mechanism of neurodegeneration, characterized by a progressive structural and functional loss of neurons, leading to heterogeneous clinical and pathological manifestations with subsequent impai…

10.29296/24999490-2024-01-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 58–64

VDAC1-DEPENDENT MITOCHONDRIAL EFFECTS OF COMPOUNDS CONTAINING THE 4-HYDROXY-3,5-DI-TRETBUTYL PHENYL SUBSTITUENT IN EXPERIMENTAL FOCAL CEREBRAL ISCHAEMIA

Introduction. Ischemic stroke is one of the most common causes of mortality and primary disability. The treatment of ischemic stroke, especially its complications, includes neuroprotective agents among which correctors of mitochondrial dysfunction stand out. A…

10.29296/24999490-2023-03-08Details ↗
ОБЗОР2022 · pp. 3–9

MITOCHONDRIAL TRANSPORT MOLECULES AS THE POTENTIAL OBJECTS FOR TARGETED THERAPY

Mitochondria are the active cell organelles whose structures (the membrane in particular) express a large number of signaling molecules, proteins mainly, that play an important regulatory role in cell active functioning. The biological activity of mitochondria…

10.29296/24999490-2022-06-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 54–59

MOLECULAR MECHANISMS OF NEUROPROTECTION OF 3-[(E)-3-(3,5-DITRET-BUTYL-4-HYDROXYPHENYL)-3-OXOPROP-1-ENYL]-6-METHOXY-CHROMENE-4-ONE IN EXPERIMENTAL TRAUMATIC BRAIN INJURY

Introduction. Neuroprotection in traumatic brain injury is a promising area of therapy for cerebral disorders. Neuroprotective effect can be implemented by a action on variety molecular targets, a change in the activity of which leads to the elimination of pat…

10.29296/24999490-2022-03-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022

MITOCHONDRIA – INTRACELLULAR TARGETS OF GEROPROTECTIVE EFFECT OF V007

Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…

10.29296/24999490-2022-01-04Details ↗
ПЕРЕДОВАЯ СТАТЬЯ2018

PHARMACOLOGICAL TREATMENT OF PARKINSON’S DISEASE: MOLECULAR ASPECTS AND PROSPECTS

Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …

10.29296/24999490-2018-02-01Details ↗
ПЕРЕДОВАЯ СТАТЬЯ2016

MOLECULAR AND CELLULAR MECHANISMS OF ALZHEIMER’S DISEASE

Alzheimer's disease being the socially significant neurodegenerative disease of the elderly, ranks 6th on the causes of death among somatic pathologies. The molecular mechanisms of Alzheimer's disease still remain unexplored until the end, and the efficacy of …

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

QUANTIFICATION OF THE NUMBER OF MITOCHONDRIAL DNA COPIES IN HUMAN OOCYTES WITH DIFFERENT MORPHOLOGICAL ABNORMALITIES

Introduction. In IVF-cycles ≈70% of human oocytes have different morphological abnormalities (dysmorphisms). Embryos from dysmorhic oocytes may have delay in development due to mitochondrial dysfunction and disorders of energy accumulation in the cell. The aim…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

MITOCHONDRIA – INTRACELLULAR TARGETS OF GEROPROTECTIVE EFFECT OF V007

Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…

10.29296/24999490-2022-01-04Details ↗

Article search and quick navigation

Navigation